Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy.

Front Endocrinol (Lausanne) · 2025 · PMC12245698 · PMID 40655397

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

marginally significantp = 0.078so close (0.05 < p ≤ 0.1)

For urinary (u) C3M, the overall linear mixed model was marginally significant (p = 0.078).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.